The role of [18F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate the diagnostic accuracy of [18F]-DCFPyL PET/MRI radiomics for the prediction of pathological grade group in prostate cancer (PCa) in therapy-naïve patients.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Eur J Nucl Med Mol Imaging

Title: European journal of nuclear medicine and molecular imaging

Publisher: Springer Science and Business Media LLC

ISSN (Electronic): 1619-7089

ISSN (Print): 1619-7070

Publication date (Electronic): Jun 2023

Volume: 50

Issue: 7

Affiliations

[1 ] Joint Department of Medical Imaging, University Medical Imaging Toronto (UMIT), University Health Network, Mount Sinai Hospital & Women's College Hospital; University of Toronto, Toronto, ON, Canada. Adriano.BassoDias@uhn.ca.

[2 ] Joint Department of Medical Imaging, University Medical Imaging Toronto (UMIT), University Health Network, Mount Sinai Hospital & Women's College Hospital; University of Toronto, Toronto, ON, Canada.

[3 ] Division of Urology, Department of Surgery, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

[4 ] Department of Radiation Oncology, Princess Margaret Cancer Center, University Health Network & University of Toronto, Toronto, ON, Canada.

[5 ] Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.

[6 ] Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada.

Article

Publisher Item ID: 10.1007/s00259-023-06136-0

DOI: 10.1007/s00259-023-06136-0

PubMed ID: 36809425

SO-VID: 98763fa5-a5b7-433c-8d19-823bbd9c4f52

History

Keywords: PET/MRI,Prostate,Radiomics

Data availability:

Keywords: PET/MRI, Prostate, Radiomics

Comments

Comment on this article

scite_

Cited by 3

See all cited by